Jump to content
Knowledge Hub

News Archive

MHRA - Compliance Monitor (CM) Overview and Application Process

4th May 2022

From April 2022, the MHRA will be running a pilot scheme to monitor companies that fail to comply with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) and are referred to the Inspection Action Group (IAG) after an inspection that has resulted in the compliance escalation process being initiated.

Read More+

EMA - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022

19th April 2022

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022

Read More+

FDA - Request for Comments.- Cybersecurity in Medical Devices

19th April 2022

FDA Request for Comments - Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions

Read More+

FDA/ICH - E8(R1) General Considerations for Clinical Studies

19th April 2022

FDA/ICH - E8(R1) General Considerations for Clinical Studies.

Read More+

EMA - Public Consultation on the Approach of Protection of Personal data

13th April 2022

The European Medicines Agency has published for public consultation a draft guidance document on how to approach the protection of personal data and commercially confidential information in documents uploaded and published in the Clinical Trial Information System (CTIS).

Read More+

ICH - Analytical Procedure Development Q14

7th April 2022

ICH ANALYTICAL PROCEDURE DEVELOPMENT Q14 - Draft version

Read More+

EC - Pharmaceutical Committee 98th Meeting Minutes

6th April 2022

Summary record - 98th meeting of the Pharmaceutical Committee (20 January 2022)

Read More+

EMA - Advice to sponsors on managing the impact of the war in Ukraine on clinical trials

6th April 2022

Advice to sponsors on managing the impact of the war in Ukraine on clinical trials

Read More+

EMA - EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice

6th April 2022

EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice

Read More+

EMA - Public Consultation ICH guideline Q14 on analytical procedure development

6th April 2022

Public Consultation open on: ICH guideline Q14 on analytical procedure development

Read More+
« Previous | Page 54 of 99 | Next »

Share